Live Chat

CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 74% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.

Close

Trade Novavax NVAX

Novavax live chart

Instrument Fundamentals

Weekly Search
Weekly
Daily
Date Close Change Change (%) Open High Low

News

Webhose 2024 Dec 20, 08:40

Wellington Management Group LLP Acquires New Holdings in Novavax, Inc. (NASDAQ:NVAX)

Novavax Inc
Webhose 2024 Dec 19, 08:26

Novavax adjusts vaccine deal with Australian government By Investing.com

Novavax Inc
Webhose 2024 Dec 19, 03:36

Novavax: Australia Cancels Delivery of Some COVID-19 Doses

Novavax Inc
Webhose 2024 Dec 18, 22:35

Novavax says Australia cancels delivery of some Covid-19 doses

Novavax Inc
Webhose 2024 Dec 18, 11:30

Novavax is as protective as other Covid vaccines, but has fewer side effects | Vox

Novavax Inc
Webhose 2024 Dec 14, 11:12

Tidal Investments LLC Has $6.32 Million Stake in Novavax, Inc. (NASDAQ:NVAX)

Novavax Inc
Webhose 2024 Dec 13, 13:04

Novavax Advances Corporate Growth Strategy Through Sanofi Partnership, Including Achievement of First $50M Milestone By Investing.com

Novavax Inc
Webhose 2024 Dec 13, 05:06

Novavax achieves $50M milestone in Sanofi partnershi By Investing.com

Novavax Inc
Webhose 2024 Dec 12, 10:38

XTX Topco Ltd Boosts Holdings in Novavax, Inc. (NASDAQ:NVAX)

Novavax Inc
Webhose 2024 Dec 12, 09:47

HC Wainwright Reaffirms “Buy” Rating for Novavax (NASDAQ:NVAX)

Novavax Inc
Webhose 2024 Dec 11, 13:48

H.C. Wainwright reiterates Buy on Novavax stock as Phase 3 CIC trial begins By Investing.com

Novavax Inc
Webhose 2024 Dec 11, 00:00

NVAX Starts Late-Stage Study on COVID-19-Flu Combo & Flu Vaccines - December 11, 2024 - Zacks.com

Novavax Inc
Webhose 2024 Dec 11, 00:00

FDA Grants Fast Track Tag to SNY's Two COVID & Flu Vaccine Candidates - December 11, 2024 - Zacks.com

Novavax Inc
Webhose 2024 Dec 10, 13:10

Novavax starts Phase 3 trial for dual COVID-19/flu vaccine By Investing.com

Novavax Inc
Webhose 2024 Dec 10, 05:06

Novavax Initiates Phase 3 Trial for COVID-19-Influenza Combination and Stand-Alone Influenza By Investing.com

Novavax Inc
Webhose 2024 Dec 10, 00:00

Novavax, Inc. (NVAX) is Attracting Investor Attention: Here is What You Should Know - December 10, 2024 - Zacks.com

Novavax Inc
Webhose 2024 Dec 08, 10:11

Two Sigma Advisers LP Has $25.25 Million Stake in Novavax, Inc. (NASDAQ:NVAX)

Novavax Inc
Webhose 2024 Dec 08, 08:28

BNP Paribas Financial Markets Cuts Stock Holdings in Novavax, Inc. (NASDAQ:NVAX)

Novavax Inc
Webhose 2024 Dec 07, 17:01

Novavax (NASDAQ:NVAX) Trading Up 10.1% - Time to Buy?

Novavax Inc
Webhose 2024 Dec 06, 16:38

Stock Traders Purchase High Volume of Call Options on Novavax (NASDAQ:NVAX)

Novavax Inc
Webhose 2024 Dec 06, 16:33

Brokerages Set Novavax, Inc. (NASDAQ:NVAX) Target Price at $17.83

Novavax Inc
Webhose 2024 Dec 06, 13:38

Investors Purchase High Volume of Novavax Call Options (NASDAQ:NVAX)

Novavax Inc
Webhose 2024 Dec 05, 00:00

Novavax to Sell Czech Manufacturing Plant to Novo Nordisk for $200M - December 5, 2024 - Zacks.com

Novavax Inc
Webhose 2024 Dec 04, 11:52

Novavax sells Czech facility to Novo Nordisk for $200 million By Investing.com

Novavax Inc
Webhose 2024 Dec 04, 10:38

Edgestream Partners L.P. Acquires New Holdings in Novavax, Inc. (NASDAQ:NVAX)

Novavax Inc
Webhose 2024 Dec 04, 10:08

Novavax sells Czech manufacturing facility to Novo Nordisk for $200 mln By Investing.com

Novavax Inc
Webhose 2024 Dec 04, 09:56

Edgestream Partners L.P. Makes New Investment in Novavax, Inc. (NASDAQ:NVAX)

Novavax Inc
Webhose 2024 Dec 04, 09:27

Novavax Rallies on Sale of Czech Facility to Novo Nordisk (1)

Novavax Inc
Webhose 2024 Dec 04, 09:04

Novavax to sell Czech manufacturing unit to Novo Nordisk for $200 mln

Novavax Inc
Webhose 2024 Dec 04, 08:32

Novavax To Sell Manufacturing Facility In Bohumil, Czech Republic To Novo Nordisk For $200 Mln

Novavax Inc
Webhose 2024 Dec 04, 07:00

Novavax Announces Sale of Czech Republic Manufacturing Site to Novo Nordisk for $200 Million | Morningstar

Novavax Inc
Webhose 2024 Dec 04, 06:35

Novavax sells Czech manufacturing facility to Novo Nordisk for $200 mn | World News - Business Standard

Novavax Inc
Webhose 2024 Nov 29, 09:44

Bank of Montreal Can Purchases 517,727 Shares of Novavax, Inc. (NASDAQ:NVAX)

Novavax Inc
Webhose 2024 Nov 29, 07:08

Novavax, Inc. (NASDAQ:NVAX) Given Average Rating of “Hold” by Brokerages

Novavax Inc
Webhose 2024 Nov 29, 07:08

Novavax, Inc. (NASDAQ:NVAX) Receives Average Rating of "Hold" from Analysts

Novavax Inc
Webhose 2024 Nov 26, 00:00

Novavax and Assembly lead infectious disease gainers in 2024 | BioWorld

Novavax Inc
Webhose 2024 Nov 22, 06:59

B. Riley Has Negative Outlook for Novavax FY2024 Earnings

Novavax Inc

Latest news

Frances Wang 2024 Dec 19, 16:00

Analyst revises Amazon stock forecast following major 'moonshot' initiative

Stocks
Frances Wang 2024 Dec 19, 16:00

Stock market today: 3 bullish stocks that J.P. Morgan Just Upgraded

Stocks
Frances Wang 2024 Dec 19, 16:00

Bitcoin news today: Jerome Powell Says Fed Won’t Hold Bitcoin

Cryptocurrencies
Frances Wang 2024 Dec 19, 16:00

Gold performance and prediction: how high could gold price go?

Commodities
UK GDP
Dyogenes Diniz 2024 Dec 19, 16:00

Week ahead: Last full week of 2024 in the Financial Markets

Forex Indices
Frances Wang 2024 Dec 18, 16:00

Stock market today: Nasdaq Hits Record Highs as Tesla Achieves New Peaks

Stocks
Frances Wang 2024 Dec 18, 16:00

Dow Jones tumbles 1,100 points: why did the stock market go down today?

Stocks
Frances Wang 2024 Dec 18, 16:00

Super Micro Shares Drop 8% Following Nasdaq 100 Removal

Stocks

Info

Spread

0.07

Spread (%)

0.8083 %

Leverage

1:5

Overnight Interest Buy

-0.0597 %

Overnight Interest Sell

-0.0292 %

Currency

USD

Trading Hours

Markets closed

Monday

14:31 - 20:59

Tuesday

14:31-17:59

Thursday

14:31-20:59

Friday

14:31-20:59

Analysis and statistics

Open

---

Previous Close

---

52 Week High/Low

--- – ---

Market cap

1393609344

Shares Outstanding

160184992

Earnings Date (Next)

2019-05-10

Div Yield

2019-05-10

Ex-Dividend Date

Forward annual dividend rate

0

Forward annual dividend yield

0

EPS

-2.19

Learn more about this instrument

Novavax Novavax Inc
Novavax, Inc., a biotechnology company, that promotes improved health by discovering, developing, and commercializing vaccines to protect against serious infectious diseases. It offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response. It focuses on urgent health challenges, which is evaluating vaccines for COVID-19, influenza, and COVID-19 influenza combination. The company is commercializing a COVID-19 vaccine, NVX-CoV2373 under the brand names of Nuvaxovid, Covovax, and Novavax COVID-19 Vaccine, adjuvanted for adult and adolescent populations as a primary series and for both homologous and heterologous booster indications. It is also developing R21/Matrix-M adjuvant malaria vaccine. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.

Related Instruments

Asset
Sell
Buy
Change (%)
View all instruments
Trustpilot
Live Chat